Ultramarine & Pigments Q1FY27: consolidated PAT +56% YoY on margin expansion to 13.2%
Consolidated is primary here, and while standalone and consolidated tell a similar top-line story, they diverge on profit growth. Ultramarine & Pigments posted consolidated revenue of ₹239.96 Cr for Q1 FY27, up 30.1% YoY from ₹184.38 Cr and 20.8% QoQ from ₹198.71 Cr. Consolidated PAT came in at ₹31.59 Cr, up 56.5% YoY from ₹20.19 Cr, with EPS at ₹10.82 versus ₹6.91 a year earlier. Standalone (parent-only) revenue of ₹218.87 Cr (+29.8% YoY) and PAT of ₹27.97 Cr (+68.2% YoY) actually grew profit faster than the consolidated entity — the roughly 12-point gap traces to subsidiary Ultramarine Specialty Chemicals, whose ₹3.52 Cr PAT this quarter on ₹24.79 Cr of income grew more slowly and diluted the group's blended growth rate.
Consolidated net profit margin expanded to 13.2% from 10.95% a year ago and roughly 7.1% last quarter. Neither the current nor the year-ago quarter carried any exceptional item, so the improvement is operating, not one-off — by contrast, the prior quarter (Q4FY26) carried a ₹1.83 Cr consolidated exceptional loss, meaning the 123% QoQ PAT jump is flattered by a soft base and shouldn't headline the story. By segment, Chemicals and Allied Products — the core inorganic-pigments business — drove the print, with consolidated segment revenue up 30.9% YoY to ₹225.03 Cr and segment profit of ₹38.27 Cr; IT Enabled Services grew 19.4% YoY to ₹14.93 Cr, a smaller but supportive contributor.
There is no formal management guidance on record for this quarter, and a web search turned up no analyst previews or consensus estimates for this print — Ultramarine & Pigments appears to carry no meaningful sell-side coverage, so the result is neither a beat nor a miss versus street, just unknown. No management press release beyond the routine SEBI board-outcome letter was available for this extraction, so no direct management commentary could be cross-checked against the numbers. The quarter's corporate calendar includes the 65th AGM on July 22, 2026, where a 300% (₹6/share) FY26 dividend was declared, and a ₹250 Cr inorganic-pigment capacity expansion project approved in May 2026 — neither shows up in this quarter's P&L yet, but both signal capital-allocation intent heading into an expansion cycle.
Going into Q2 FY27, the key markers are whether the 13.2% consolidated NPM holds without the tailwind of an easy prior-quarter exceptional-item comparison, and early execution/capex updates on the ₹250 Cr pigment project. The subsidiary mix — Ultramarine Specialty Chemicals, with total assets of ₹203.62 Cr and ₹3.52 Cr PAT this quarter — is worth tracking since it is currently growing slower than the standalone business and diluting group profit growth.
